• 한국원자력학회:학술대회논문집
• /
• 한국원자력학회 1998년도 춘계학술발표회논문집(2)
• /
• pp.725-729
• /
• 1998

방사성 동위원소를 이용한 체외진단 측정법으로 RIA가 가장 널리 쓰여져 왔으나, 결합분획과 유리분획의 분리과정에서 오는 번거로운 단점을 개선하기 힘들었다. 1979년 Hart와 Greenwald에 의해 소개된 섬광근접측정법(Scintillation Proximity Assay, SPA)을 이용하여 RIA의 단점을 극복하고자 하는 연구가 시작되었다 주로 사용되는 방사성동위원소로 $^3$H, $^{125}$/I이 추천되는 핵종이며, 이 중에서 $^{125}$/I을 이용한 hCG(human chorionic gonadotropin) 체외진단법으로서 SPA의 기초연구를 수행하였다. SPA bead와 방사능 크기에 따라 측정되는 자연계수치의 증가와 hCG 표준물질을 농도별로 희석하여 유의성을 가지고 있는지 확인하였고, hCG 농도가 높은 것으로 판명된 환자의 혈청을 측정하여 임상적용의 가능성을 확인하였다.

• 대한한방부인과학회지
• /
• 제18권1호
• /
• pp.234-241
• /
• 2005

Hyperemesis gravidarum is a severe and intractable form of nausea and vomiting in pregnancy. It is a diagnosis of exclusion and may result in weight loss; nutritional deficiencies; and abnormalities in fluids, electrolyte levels, and acid-base balance. The peak incidence is at 8-12 weeks of pregnancy, and symptoms usually resolve by week 16. Interestingly, nausea and vomiting of pregnancy is generally associated with a lower rate of miscarriage. The cause of severe nausea and vomiting in pregnancy has not been identified. Extreme nausea and vomiting may be related to elevated levels of estrogens or human chorionic gonadotropin. Once the diagnosis is made, treatment consists of mainly supportive care. Until vomiting is controlled, these patients should be maintained as NPO. We treated 1 patient who had hyperemesis gravidarum and visited Kyung-Won Incheon Oriental Hospital by Herbal medication, acupuncture, moxa and nega therapy and got good result from them.

• 한국양식학회지
• /
• 제11권4호
• /
• pp.513-519
• /
• 1998

인간의 태반성 성선자극 호르몬(HCG) 또는 성선자극 호르몬-방출 호르몬 유도체(GnRH-a) 단독 주사와 HCG+GnRH-a, GnRH-a+prostaglandin E sub(2) (PGF sub(2)), GnRH-a+pimozide를 복합적으로 주사하여 성숙한 암컷 쏘가리에서 배란 유도 실험을 하였다. 호르몬과 유도체의 반응 효과는 배란후 인공 수정하여 수정율과 배체형성율을 측정하여 결정하였다. 일반적으로 GnRH-a 실험군이 HCG 실험군에 비해서 수정율과 배체형성율 및 부화율이 높았다. HCG(5,000 IU/kg)+(GnRH-a(10 ${\mu}$g), GnRH-a(10 ${\mu}$g/kg)+PG$F^2$(500 ng/kg) 및 GnRH-a(10 ${\mu}$g/kg)+pimozide(1-5 mg/kg)에서 89% 이상의 높은 부화율을 보였다. 본 연구에서 사용된 성성숙 호르몬과 자극물질로 처리된 모든 암컷에서 배란이 유도되었지만, HCG+GnRH-a+dopamine과 GnRH-a+PG$F_2$+indometacin 처리군에서는 배란이 억제되었다. 이들의 결과는 산란시기에 여러 가지 성성숙 호르몬과 관련된 호르몬과 성성숙 억제물질(GRIF)이 분비된다는 점을 시사한다.

• Fisheries and Aquatic Sciences
• /
• 제25권1호
• /
• pp.12-19
• /
• 2022

In the present study, we investigated the effects of recombinant eel gonadotropins (rec-GTHs) on maturation induction in immature ovarian culture in vitro and sex steroid hormones in vivo in the Japanese eel Anguilla japonica. To study the in vitro effects of rec-GTHs on estradiol-17β (E2) production in immature ovarian tissues, ovarian tissues were incubated with different doses of rec-follicle-stimulating hormone (rec-FSH) or rec-luteinizing hormone (rec-LH). The results revealed that the E2 levels in the rec-FSH (0.1, 0.5, or 1 ㎍/mL)- and rec-LH (0.1 or 0.5 ㎍/mL)-treated groups were significantly higher than those in the female eels from the control group. Furthermore, to investigate the in vivo effects of rec-GTHs on the gonadosomatic index (GSI) and plasma sex steroid hormone levels, the eels were injected intraperitoneally with eel's ringer (control), salmon pituitary extract (SPE; for female eels), human chorionic gonadotropin (hCG; for male eels), rec-FSH, rec-LH, and rec-FSH + rec-LH once a week. The results revealed that except for the SPE and the hCG groups, none of the groups exhibited a significant difference in GSI values. However, in vivo plasma E2 levels increased at the end of 4 weeks after rec-FSH treatment in female eels. Based on these results, it is suggested that rec-GTHs may have a positive effect on sexual maturation in female eels; however, further studies on complementary rec-protein production systems and additional glycosylation of rec-hormones are needed to elucidate hormone bioactivity in vivo and in vitro.

• Journal of Genetic Medicine
• /
• 제17권2호
• /
• pp.68-72
• /
• 2020

Purpose: Trisomy 21, the cause of Down syndrome (DS) with various medical problems, is the most common aneuploidy during the fetal period. For diagnosis, a non-invasive screening test using maternal blood, which cannot be confirmed and invasive confirmation test with a risk of miscarriage, may be performed. The trophoblast retrieval and isolation of the cervix (TRIC) have been proposed by some researchers as an alternative to overcome the limitations of current tests. We experimented using TRIC to identify the possibility of trisomy 21 for the first time in Asia. Materials and Methods: Three cases of DS were analyzed confirmed by invasive tests (chorionic villus sampling, amniocentesis). All samples of trophoblasts immediately were immersed in phosphate-buffered saline and processed with formalin for fixation. The trophoblasts were isolated using an anti-human leukocyte antigen-G antibody coupled to magnetic nanoparticles. β-human chorionic gonadotropin (hCG)-expressing cells were considered as trophoblast cells, and the detection rate calculated. DS was confirmed by fluorescence in situ hybridization (FISH). Results: The mean trophoblast detection rate using β-hCG was 78.1%, and the detection rate using FISH was 22.2%. In all cases, the trisomy of chromosome 21 was identified. Conclusion: Trophoblast can be obtained from the five weeks of gestation and has a high detection rate, so it is noted that it can replace the current prenatal genetic test. To realize the clinical application as a prenatal genetic test, we will need additional efforts to identify trisomy 21 as well as other chromosomal abnormalities in future large-scale studies.

• Clinical and Experimental Reproductive Medicine
• /
• 제14권2호
• /
• pp.109-118
• /
• 1987

Ninety-one patients with irreparable tubal disease underwent in Vitro Fertilization-Embryo Transfer (IVF-ET) in Seoul National University Hospital. Ovulation was stimulated in 104 cycles by human menopausal gonadotropin (HMG) or follicular stimulating hormone (FSH)/human chorionic gonadotropin (HCG). The patients were classified as high (>900 pg/ml), intermediate (400-900 pg/ml), or low (<400pg/ml) responder according to preovulatory $E_2$ response and four $E_2$ patterns were found. The overall pregnancy rate per cycle in this consecutive series was 11.5% (n=12). The number of preovulatory oocytes per cycle was higher significantly in intermediate and high responder group than in low responder group (P<0.01), While the number of immature oocytes per cycle significantly higher in low responder group than high and intermediate responder group (P<0.01). The pregnancy rate in each responder group was not signigicant. According to the $E_2$ pattern of response, there was no significant difference in number of the immature and preovulatory oocytes recovery per cycle. There was a apparently direct relationship between the preovulatory $E_2$ pattern and pre gnancy rate was noted.

• Clinical and Experimental Reproductive Medicine
• /
• 제15권1호
• /
• pp.25-34
• /
• 1988

The intrafo1licular echoes of cumulus oophoruses within ovarian follicles were assessed with the use of ultrasound in 86 women taking part in an in vitro fertilization(IVF) or gamete intrafallopian transfer(GIFT) program, stimulated with pure follicle-stimulating hormone(FSH)/human menopausal gonadotropin(hMG)/human chorionic gonadotropin (hCG). When intrafo1licular echoes were clearly separated from the follicular wall or relatively dispersed within the follicle, they were considered to be a dissociated cumulus, and when they were only slightly prominent from the follicular wall, they were suspected to be a nondissociated cumulus. A cumulus was seen in 62.1% of the follicles larger than 10 mm diameter and 75.1% of them were dissociated. The larger the follicles in size, the more the cumuluses in number and dissociation. The number of follicles and intrafollicular echoes per woman was not different whether or not she would be pregnant, but the number of dissociated cumuluses was significantly more in pregnant women. The number of observed dissociated cumuluses correlated significantly with the number of recovered mature oocytes. When an intrafollicular echo is seen, it can be taken as evidence of a sign of maturity of that particular follicle and oocyte. Ultrasonographic monitoring of intrafollicular echoes and follicular size is very helpful to predict follicular maturation in ovulation stimulation cycles.

• Journal of Veterinary Science
• /
• 제21권3호
• /
• pp.48.1-48.18
• /
• 2020

Background: Mature oocytes at the metaphase II status (MII-stage oocytes) played an important role in assisted reproductive technology in non-human primates. Objectives: In order to improve the proportion of MII-stage oocytes retrieval, three different superovulation protocols were performed on 24 female cynomolgus monkeys. Methods: All the monkeys received once-daily injection of follicle-stimulating hormone (25 international unit [IU]) on day 3 of the menstruation, 3-day intervals, twice daily for 8-12 days until the time of human chorionic gonadotropin (1,500 IU) injection, on the 14-17th day of menstruation collecting oocytes. The difference between protocol I and protocol II was that 0.1 mg the gonadotropin-releasing hormone agonist was injected on day 1 of the menstruation, while the difference between personalized superovulation protocol and protocol II was that oocytes could be collected on the 14-17th day of menstrual cycle according to the length of each monkey. Results: The total number of oocytes harvested using the personalized superovulation protocol was much higher than that using protocol I (p < 0.05), and the proportion of MII-stage oocytes was significantly greater than that from either superovulation protocol I or II (p < 0.001 and p < 0.01 respectively), while the proportion of immature oocytes at the germinal vesicle was less than that from superovulation protocol I (p < 0.05). Conclusions: The personalized superovulation protocol could increase the rate of MII-stage oocytes acquired, and successfully develop into embryos after intracytoplasmic sperm injection, and eventually generated fetus.

• 환경생물
• /
• 제27권4호
• /
• pp.369-374
• /
• 2009

멸종위기에 처한 꼬치동자개(Pseudobagrus brevicorpus)의 보전과 복원을 위한 기초 자료를 제공하기 위하여 인공사육 환경에서 사육된 종묘에서 친어까지의 성장과 성성숙 특징들을 조사하였다. 부화 후 698일의 인공사육 기간 동안 전장과 체중은 각각 $89.22{\pm}10.29mm$와 $70.93{\pm}7.68g$로 성장하였고, 전장 (TL)과 체중(BW)의 관계는 $BW=5{\times}10^{-5}\;TL^{2.678}$ ($R^2=0.995$)로 나타났으며, 생존율은 74.2%였다. 암컷과 수컷의 성비는 1 (암컷, 471) : 1 (수컷, 473)이었다. 부화 후 663일째에 암컷의 전장과 체중은 각각 $78.38{\pm}0.92\;mm$과 $6.38{\pm}0.20\;g$로 나타나 수컷의 $87.44{\pm}1.07mm$와 $8.43{\pm}0.31g$에 비해 높았으나, 비만도는 암컷이 수컷에 비해 유의적으로 값을 보였다(P<0.05). 암컷 1마리당 포란수는 평균 734개(508~867개)였고, 난경은 0.04~1.65mm의 범위를 보였다. 인공 사육된 친어는 만 2년이 되던 6월 초순에 인간 융모성 고나도트로핀(human chorionic gonadotropin: HCG)을 주사한 후 1~2일 사이에 산란이 가능하였고, 부화된 개체는 평균 216마리(113~338마리)였다.

• 한국동물학회지
• /
• 제28권4호
• /
• pp.245-256
• /
• 1985

흰쥐의 여포내 혹은 구멍만 낸 여포내의 난자, 또는 다른 여포에 옮겨 넣은 난자의 경우, 그 여포를 17시간 배양하여도 배양액에 hCG가 첨가되지 않는 한, 여포내 난자는 GV를 유지하였다. 즉, 기본 배양액에서 배양할 경우 88.8%-95.2%의 여포내 난자가 GV를 유지하였다. 그러나, hCG를 배양액에 첨가하였을 때 대부분이 핵막붕괴(GVBD)를 일으키고 단지 11.1%-19.4%의 여포내 난자만이 GV를 유지하였다. 난자를 dbcAMP나 IBMX가 들어있는 배양액에서 4시간 동안 배양한 후 다른 여포에 옮겨 넣어 계속 17시간동안 배양할 경우에도 그 결과가 앞의 것과 같았다. 즉 dbcAMP가 들어있는 배양액에서 배양한 후 다른 여포로 옮겨 넣었을 때 그 여포를 기본 배양액으로 배양하면 86.1%의 난자가 GV를 유지하였으며 만일 배양액에 hCG를 첨가하면 단지 13.1%의 난자가 GV를 유지하였다. 또한 IBMX가 들어있는 배양액에서 먼저 배양한 경우에는 결국 여포는 난자의 성숙을 억제하는 환경을 제공하고 있으며 이같은 억제효과는 배양액에 첨가된 hCG에 의하여 소실된다.